Placental MFSD2a transporter is related to decreased DHA in cord blood of women with treated gestational diabetes

In offspring of women with GDM treated either with diet or insulin, higher fetal fat accretion and lower placental MFSD2a contribute to reduce DHA availability. Lyso-PL appear to contribute to materno-fetal DHA transport.